Phage Therapy in a Resisting World (Highlights the potential of phage therapy against antibiotic resistance)

Phage Therapy Market worth $ 116.6 Million by 2028 - Exclusive Report by InsightAcea Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Phage Therapy Market- by Product(Oral, External Application and Surgical Treatment), Application (Human Medicine, Veterinary Science and Others (Agriculture, dentistry, etc.)), Trends, Industry Competition Analysis, Revenue and Forecast To 2028."

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1094

According to the latest research by InsightAce Analytic, the globalPhage Therapy market is expected to reach US$ 116.6 Million by 2028, with a CAGR of 18.9% during a forecast period of 2024-2031.

Phage Therapy: A Targeted Approach to Bacterial Infections
Phage therapy, also known as bacteriophage therapy, utilizes bacteriophages (phages) to combat bacterial infections. Phages are viruses that specifically target and infect bacteria, offering several advantages over traditional antibiotics:
• Specificity: Phages only target the bacteria they are designed to infect, leaving healthy gut bacteria unharmed. This helps maintain a balanced gut microbiome.

• Versatility: Phages can be administered through various routes, including orally, topically, or during surgery.

• Safety: Composed primarily of proteins and nucleic acids, phages are generally non-toxic.

• Ease of Discovery and Development: New phages can be readily discovered and developed into phage therapy treatments.

• Compatibility with Antibiotics: Phage therapy can be combined with some antibiotics for a synergistic effect.

Market Drivers for Phage Therapy
The phage therapy market is experiencing growth due to several factors:
• Rise of Antibiotic Resistance: The increasing prevalence of antibiotic-resistant bacteria is a major driver. Phage therapy offers a promising alternative to traditional antibiotics in combating these resistant strains.

• Food Safety Concerns: The use of phage therapy in the food and beverage industry to control foodborne bacterial contamination is another growth factor.
• Targeted Therapies: The development of phage therapies that target specific bacterial strains is a growing trend.

• Increased R&D Investments: Rising investments in research and development for phage therapy applications are propelling market growth.
Challenges and Considerations

Despite its potential, the phage therapy market faces some challenges:
• Limited Expertise: A lack of skilled professionals and specialists trained in phage therapy can hinder wider adoption.

• High Drug Development Risk: The high failure rate of drugs during development is a hurdle for the market.

Market Opportunities
• Technological Advancements: The development of advanced phage therapy platforms by companies in the field presents exciting opportunities.

• Expanding Patient Population: The growing patient population in developing economies, particularly those with limited access to effective antibiotics, creates a significant market potential.

I hope this revision improves readability by separating the explanation of phage therapy from the market analysis and highlighting the specific drivers, challenges, and opportunities.

North America is anticipated to contribute to the Phage Therapy market. The main driver of market growth is the rising demand for probiotic supplements to enhance gut health by employing phage probiotics. Furthermore, the nation's leading manufacturers are eager to increase the market reach of their flagship goods and services. For this, many top manufacturers today also provide cutting-edge phage therapy-based solutions.

In addition, the Asia PacificPhage Therapy market is expected to register significant growth. Phage therapy has attracted increased interest as antibiotic treatments fail to effectively treat infections like multidrug-resistant Staphylococcus aureus. Phage treatment research is constantly being conducted with pharmaceutical corporations and government institutions, which has greatly increased the potential for phage therapy in this area.

Major market players operating in the Phage Therapy market include
Armata Pharmaceuticals, Inc., Adaptive Phage Therapeutics, AmpliPhi Biosciences, BiomX (MBcure Ltd.), C3J Therapeutics, Enbiotix, Eligo Bioscience, Intralytix, Inc., InnoPhage, iNtODEWorld, Locus Biosciences, MicroPhage, Inc., Phage International, PhagoMedBiopharma GmbH, PherecydesPharma SA, TechnoPhage, Phagelux, SNIPR BIOME, and Microgen Russia.

Recent collaborations and agreements in the market:
• In 2020, a new e-Commerce site for Optibac probiotics was launched by Ridgeway, a digital firm, to increase consumer compliance and repeat purchases of phage therapy supplements.

• In 2019, IntraLytix Inc. created various innovative phage therapies against Shigella intended for human ingestion and numerous phage preparations for directly eliminating harmful bacteria.

Curious about this latest version of the report?Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1094
Market Segments

Global Phage Therapy Market, by Product, 2022-2028 (Value US$ Mn)
• Oral
• External Application
• Surgical Treatment

Global Phage Therapy Market, by Application, 2022-2028 (Value US$ Mn)
• Human Medicine
• Veterinary Science
• Others (Agriculture, dentistry, etc.)

Global Phage Therapy Market, by Region, 2022-2028 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• U.S.
• Canada

Europe Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Phage Therapy Market, by Country, 2022-2028 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Phage Therapy market
 To receive an industry overview and future trends of thePhage Therapy market
 To analyzethe Phage Therapy market drivers and challenges
 To get information on the Phage Therapy market value (US$ Mn) forecast to 2028
 Significant investments, mergers &acquisitions in the Phage Therapy marketindustry

For More Information @ https://www.insightaceanalytic.com/enquiry-before-buying/1094

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.